28 Results of a phase iii randomized controlled study comparing the survival of patients with unresectable hepatocellular carcinoma (HCC) treated with nolatrexed (NOL) or doxorubicin (DOX)
2006
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
10
Citations
NaN
KQI